EyePoint Pharmaceuticals
EYPT
#6028
Rank
A$1.47 B
Marketcap
A$17.54
Share price
5.75%
Change (1 day)
81.70%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2025 (TTM): -A$0.36 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are A$31.37 Million. a decrease over its 2024 earnings that were of -A$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 -A$0.33 Billion63.24%
2024 -A$0.2 Billion104.29%
2023 -A$97.48 Million-29.88%
2022 -A$0.14 Billion87.2%
2021 -A$74.26 Million38.58%
2020 -A$53.59 Million-24.56%
2019 -A$71.03 Million
2017 -A$32.4 Million22.59%
2016 -A$26.43 Million-8.02%
2015 -A$28.73 Million-296.09%
2014 A$14.65 M-174.02%
2013 -A$19.8 Million37.42%
2012 -A$14.41 Million-56.29%
2011 -A$32.95 Million-1062.38%
2010 A$3.42 M-250.43%
2009 -A$2.28 Million-89.5%
2008 -A$21.69 Million
2005 -A$13.38 Million56.99%
2004 -A$8.52 Million73.7%
2003 -A$4.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-A$3.04 Million-99.07% Bahamas
NRC Health
NRC
A$38.69 M-111.90%๐Ÿ‡บ๐Ÿ‡ธ USA